ARTICLE

Year : 2016  |  Volume : 5  |  Issue : 5  |  Page : 252-253

Use of WGS in Mycobacterium tuberculosis routine diagnosis

Daniela M Cirillo¹, Andrea M Cabibbe¹, Maria Rosaria De Filippo¹, Alberto Trovato¹, Tullia Simonetti², Gian Maria Rossolini², Enrico Tortoli^1
1 Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Via Olgettina 60, Milan, Italy
² Ospedale Careggi, Florence, Italy

Correspondence Address:
Daniela M Cirillo
Head of Emerging Bacterial Pathogens Unit, WHO Collaborating Centre and TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milano
Italy

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.1016/j.ijmyco.2016.09.053

Objective/background: Whole Genome Sequencing (WGS) is becoming affordable with overall costs comparable to other tests currently in use to perform the diagnosis of drug-resistant tuberculosis (TB) and cluster analysis. The WGS approach allows an “all-in-one” approach providing results on expected sensitivity of the strains, genetic background, epidemiological data, and indication of risk of laboratory cross-contamination.
Methods: Although ideal, WGS from the direct diagnostic specimen is not yet standardized, and to date the two most promising approaches are WGS from early positive liquid culture and targeted sequencing from diagnostic specimens using Next-Generation Technology. Both have advantages and disadvantages. Sequencing from early MGIT requires positive cultures, whereas targeted sequencing can be performed from a specimen positive for Mycobacterium tuberculosis with a consistent gain in time to information. The aim of this study is to evaluate the feasibility and cost of using WGS with a centralized approach to speed up diagnosis of TB in a low-incidence country.
Methods: From March 2016 to September 2016, we collected and processed by WGS 89 early positive routine MGIT960 tubes. Time to diagnosis and accuracy of this technique were compared with those of standard testing performed in a regular laboratory. A 2-mL aliquot of early positive MGIT was processed, starting with heat inactivation. DNA was then isolated by using the Maxwell 16 Cell DNA Purification Kit and Maxwell 16 MDx for automated extraction. Paired-end libraries of read-length 75–151bp were prepared using the Nextera XT DNA Sample Preparation kit, and sequenced on Illumina Miseq/Miniseq platform (based on the 1st available run). Total variant calling was performed according to the pipeline of the Phyresse web-tool. The DNA isolation step required 30min for inactivation plus 30min for extraction. The concentration obtained ranged from 0.1 to 1 ng/ μL, suitable for library preparation. Samples were sequenced with a turnaround time of 24–48h. The percentage of reads mapped to the H37Rv reference genome was 83% on average. The mean read coverage was 65×. The main challenge was the presence of nonmycobacterial DNA contamination in a variable amount. Lineage detection was possible for all cases, and mutations associated with drug resistance to antitubercular drugs were examined. We observed high diagnostic accuracy for species identification and detection of full drug resistance profile compared to standard DST testing performed in MGIT.
Results: Two events of recent transmissions including respectively three and two patients were identified, and two laboratory cross-contaminations were investigated and confirmed based on the analysis. Time to availability of report was about 72h from MGIT positivity compared to up to 6–9 weeks for XDR-TB diagnosis with standard testing. In addition to speed, the main advantages were the availability of a full prediction of resistance determinants for rifampicin-resistant cases, and the fast detection of potential cross-contaminations and clusters to guide epidemiological investigation and cross-border tracing. Cost analysis showed that the cost per strain was approximately €150 inclusive of staff cost, reagents, and machine cost.
Conclusion: WGS is a rapid, cost-effective technique that promises to integrate and replace the other tests in routine laboratories for an accurate diagnosis of DR-TB, although it is suitable nowadays for cultured samples only.

Keywords: Antitubercular drugs, Mycobacterium tuberculosis, WGS

Conflicts of interest

This article has been cited by 1 Analysis of the twenty-six largest outbreaks of tuberculosis in Aragon using whole-genome sequencing for surveillance purposes Jessica Comín, Alberto Cebollada, Daniel Ibarz, Jesús Viñuelas, Juan Sahagún, Luis Torres, María-José Iglesias, Sofía Samper Scientific Reports. 2022; 12(1) [Pubmed] | [DOI] 2 Tuberkulose im Erwachsenenalter Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, Hilte Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Christoph Lange, Florian P. Maurer, Albert Nienhaus, Ralf Otto-Knapp, Martin Priwitzer, Elvira Richter, Helmut J.F. Salzer, Otto Schoch, Nicolas Schönfeld, Ralf Stahlmann, Torsten Bauer Pneumologie. 2022; 76(11): 727 [Pubmed] | [DOI] 3 Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance Mirae Park, Ajit Lalvani, Giovanni Satta, Onn Min Kon BMC Infectious Diseases. 2022; 22(1) [Pubmed] | [DOI] 4 The MtZ Strain: Molecular Characteristics and Outbreak Investigation of the Most Successful Mycobacterium tuberculosis Strain in Aragon Using Whole-Genome Sequencing Jessica Comín, Jan Madacki, Isabel Rabanaque, María Zúñiga-Antón, Daniel Ibarz, Alberto Cebollada, Jesús Viñuelas, Luis Torres, Juan Sahagún, Christophe Klopp, Jesús Gonzalo-Asensio, Roland Brosch, María-José Iglesias, Sofía Samper Frontiers in Cellular and Infection Microbiology. 2022; 12 [Pubmed] | [DOI] 5 Prevalence of non-tuberculosis mycobacteria among samples deposited from the National Tuberculous Reference Laboratory of Iran (2011-2018) Saman Ayoubi, Parissa Farnia, Poopak Farnia, Jafar Aghajani, Jalaledin Ghanavi, AliAkbar Velayati Asian Pacific Journal of Tropical Medicine. 2021; 14(10): 451 [Pubmed] | [DOI] 6 Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture Sequencing Ya He,Ziying Gong,Xiaokai Zhao,Daoyun Zhang,Zhongshun Zhang Frontiers in Cellular and Infection Microbiology. 2020; 10 [Pubmed] | [DOI] 7 False-Positive Mycobacterium tuberculosis Detection: Ways to Prevent Cross-Contamination Mohammad Asgharzadeh,Mahdi Asghari Ozma,Jalil Rashedi,Behroz Mahdavi Poor,Vahid Agharzadeh,Ali Vegari,Behrooz Shokouhi,Khudaverdi Ganbarov,Nima Najafi Ghalehlou,Hamed Ebrahmzadeh Leylabadlo,Hossein Samadi Kafil Tuberculosis and Respiratory Diseases. 2020; 83(3): 211 [Pubmed] | [DOI] 8 Successful introduction of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosis into naïve settings Kadri Klaos,Anna Agejeva,Tiina Kummik,Sirje Laks,Olesja Remets,Sirje Sasi,Anneli Tann,Piret Viiklepp,Alan Altraja International Journal of Infectious Diseases. 2020; [Pubmed] | [DOI] 9 A new DNA sensor system for specific and quantitative detection of mycobacteria Oskar Franch,Xiao Han,Lærke Bay Marcussen,Asger Givskov,Marie Bech Andersen,Adwait Anand Godbole,Charlotte Harmsen,Niels Nørskov-Lauritsen,Jonas Thomsen,Finn Skou Pedersen,Yilong Wang,Donglu Shi,Christian Wejse,Lone Pødenphant,Valakunja Nagaraja,Johanna Bertl,Magnus Stougaard,Yi-Ping Ho,Marianne Smedegaard Hede,Rodrigo Labouriau,Birgitta Ruth Knudsen Nanoscale. 2019; 11(2): 587 [Pubmed] | [DOI] 10 Retrospective Analysis of Archived Pyrazinamide Resistant Mycobacterium tuberculosis Complex Isolates from Uganda—Evidence of Interspecies Transmission Sylvia I. Wanzala,Jesca Nakavuma,Dominic Travis,Praiscillia Kia,Sam Ogwang,Wade Ray Waters,Tyler Thacker,Timothy Johnson,Syeda Anum Hadi,Srinand Sreevatsan Microorganisms. 2019; 7(8): 221 [Pubmed] | [DOI] 11 Whole genome sequencing–based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations Estefanía Abascal,Laura Pérez-Lago,Miguel Martínez-Lirola,Álvaro Chiner-Oms,Marta Herranz,Imane Chaoui,Iñaki Comas,My Driss El Messaoudi,José Antonio Garrido Cárdenas,Sheila Santantón,Emilio Bouza,Darío García-de-Viedma Eurosurveillance. 2019; 24(4) [Pubmed] | [DOI] 12 Drug-resistant Mycobacterium tuberculosis : Epidemiology and role of morphological alterations Ali Akbar Velayati,Parissa Farnia,Sven Hoffner Journal of Global Antimicrobial Resistance. 2018; 12: 192 [Pubmed] | [DOI] 13 Analysis of potential household transmission events of tuberculosis in the city of Belem, Brazil Emilyn Costa Conceição,Arthur Emil dos Santos Guimarães,Maria Luíza Lopes,Ismari Perini Furlaneto,Yan Corrêa Rodrigues,Marília Lima da Conceição,Wandyra Araújo Barros,Ninarosa Calzavara Cardoso,Abhinav Sharma,Luana Nepomuceno Gondim Costa Lima,Harrison Magdinier Gomes,Rafael Silva Duarte,Cristiane Frota,Liliana K. Rutaihwa,Sebastien Gagneux,Philip Noel Suffys,Karla Valéria Batista Lima Tuberculosis. 2018; 113: 125 [Pubmed] | [DOI] 14 Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study Nathan C Bahr,Edwin Nuwagira,Emily E Evans,Fiona V Cresswell,Philip V Bystrom,Adolf Byamukama,Sarah C Bridge,Ananta S Bangdiwala,David B Meya,Claudia M Denkinger,Conrad Muzoora,David R Boulware,Darlisha A Williams,Kabanda Taseera,Dan Nyehangane,Mugisha Ivan,Patrick Orikiriza,Joshua Rhein,Kathy Huppler Hullsiek,Abdu Musubire,Katelyn Pastick,Pamela Nabeta,James Mwesigye,Radha Rajasingham The Lancet Infectious Diseases. 2017; [Pubmed] | [DOI] 15 Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review F. Tagini,G. Greub European Journal of Clinical Microbiology & Infectious Diseases. 2017; [Pubmed] | [DOI] 16 Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice I.D. Olaru,H. Patel,K. Kranzer,N. Perera Clinical Microbiology and Infection. 2017; [Pubmed] | [DOI] 17 Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping T. Phuong Quan,Zharain Bawa,Dona Foster,Tim Walker,Carlos del Ojo Elias,Priti Rathod,Zamin Iqbal,Phelim Bradley,Janet Mowbray,A. Sarah Walker,Derrick W. Crook,David H. Wyllie,Timothy E. A. Peto,E. Grace Smith,Daniel J. Diekema Journal of Clinical Microbiology. 2017; 56(2): e01480-17 [Pubmed] | [DOI]